Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

BRADLEY M BLOCK

Allopathic & Osteopathic Physicians Family Medicine

NPI
1205819307
CMS profile
191172
Location
OVIEDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$189.20

11 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $189.20 11

By paying entity

PY2022 · entire year · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $57.22 2
Merck Sharp & Dohme LLC $26.58 2
GlaxoSmithKline, LLC. $25.65 2
Amgen Inc. $18.12 1
PFIZER INC. $16.00 1
Lilly USA, LLC $15.99 1
SANOFI PASTEUR INC. $14.83 1
Novartis Pharmaceuticals Corporation $14.81 1

Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

BRADLEY M BLOCK

NPI 1205819307 · CMS profile ID 191172

Allopathic & Osteopathic Physicians / Family Medicine

OVIEDO, FL

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1205819307?year=2022&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
BRADLEY M BLOCK, NPI 1205819307, CMS profile ID 191172. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1205819307?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). BRADLEY M BLOCK, NPI 1205819307, CMS profile ID 191172. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1205819307?year=2022&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
BRADLEY M BLOCK, NPI 1205819307, CMS profile ID 191172, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–11 of 11 matching records. This page contains 11 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1205819307?year=2022&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

11 matching records · $189.20 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 11 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–11 of 11.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
GlaxoSmithKline, LLC. $12.9212/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945097765 CMS
Merck Sharp & Dohme LLC $12.6309/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944704509 CMS
ABBVIE INC. $28.7307/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890624859 CMS
Lilly USA, LLC $15.9906/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 917914975 CMS
Amgen Inc. $18.1206/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939917719 CMS
SANOFI PASTEUR INC. $14.8305/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 937302411 CMS
Merck Sharp & Dohme LLC $13.9504/20/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944710441 CMS
PFIZER INC. $16.0004/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 949126031 CMS
Novartis Pharmaceuticals Corporation $14.8102/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893535767 CMS
ABBVIE INC. $28.4901/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890624857 CMS
GlaxoSmithKline, LLC. $12.7301/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 945097767 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $205.15 15
PY2020 $3,246.75 19
PY2021 $143.76 10
PY2022 $189.20 11
PY2023 $1,359.11 9
PY2024 $376.65 20
PY2025 $4,527.48 9

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $463,347.97 19
PY2024 Recipient $32,803.00 1
PY2024 Principal investigator $565,590.10 69
PY2023 Recipient $285.00 1
PY2023 Principal investigator $529,627.42 655
PY2022 Recipient $610.00 1
PY2022 Principal investigator $122,619.06 206
PY2021 Recipient $396.44 1
PY2021 Principal investigator $386,856.51 126
PY2020 Recipient $2,077.00 3
PY2020 Principal investigator $684,365.10 151
PY2019 Recipient $1,843.74 2
PY2019 Principal investigator $278,906.72 78

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

127 records in PY2021

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694585
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694595
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694605
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694615
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694625
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694635
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694641
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694651
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694661
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694671
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694681
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810694691
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810695415
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810695423
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810695433
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810695441
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810695451
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810695461
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771013
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771020
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771029
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771033
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771039
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771047
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771065
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771070
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771075
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771081
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771086
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771093
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771775
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771785
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771793
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771803
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270863
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270873
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270883
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270893
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270903
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270911
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270921
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270939
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270949
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270959
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270969
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270977
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272475
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272485
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272505
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272515
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272525
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272531
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272541
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272551
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272561
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272568
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272577
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338683
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338693
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338703
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338713
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338723
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338733
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338743
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338753
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338761
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338771
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338781
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338791
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338801
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811341423
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811341433
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811341623
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811341633
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811341643
Principal investigator 1 Novo Nordisk AS $17.10 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811342449
Principal investigator 1 Novo Nordisk AS $34.14 12/27/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811342459
Principal investigator 1 PFIZER INC. $352.45 12/23/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832573137
Principal investigator 1 Novo Nordisk AS $1,778.63 12/22/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771058
Principal investigator 1 PFIZER INC. $5,384.85 12/07/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832573127
Principal investigator 1 Novo Nordisk AS $2,918.27 11/24/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272495
Principal investigator 1 PFIZER INC. $1,077.30 11/23/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675125
Principal investigator 1 PFIZER INC. $691.60 11/05/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832677253
Principal investigator 1 Novo Nordisk AS $3,366.58 10/29/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270929
Principal investigator 1 PFIZER INC. $2,493.75 10/22/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675911
Principal investigator 1 PFIZER INC. $691.60 10/09/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675117
Principal investigator 1 Myovant Sciences Inc. $10,075.00 09/29/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
AN INTERNATIONAL PHASE 3 DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF RELUGOLIX WITH ESTRADIOL AND NORETHINDRONE ACETATE IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS No dispute reported 06/30/2026 835053583
Principal investigator 1 Myovant Sciences Inc. $282.10 09/29/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH LLC
AN INTERNATIONAL PHASE 3 DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED WITHDRAWAL STUDY OF RELUGOLIX WITH ESTRADIOL AND NORETHINDRONE ACETATE IN WOMEN WITH HEAVY MENSTRUAL BLEEDING ASSOCIATED WITH UTERINE FIBROIDS No dispute reported 06/30/2026 835053585
Principal investigator 1 Novo Nordisk AS $3,627.58 09/24/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771053
Principal investigator 1 Novo Nordisk AS $3,627.58 09/24/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811273487
Principal investigator 1 PFIZER INC. $1,077.30 09/22/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675919
Principal investigator 1 PFIZER INC. $47.88 09/08/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675135
Principal investigator 1 PFIZER INC. $1,802.15 09/04/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832674329
Principal investigator 1 Novo Nordisk AS $1,857.95 08/30/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810695403
Principal investigator 1 PFIZER INC. $1,360.59 08/24/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832674935
Principal investigator 1 PFIZER INC. $9,360.59 08/06/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832674951
Principal investigator 1 Novo Nordisk AS $4,470.22 07/28/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811338673
Principal investigator 1 PFIZER INC. $704.90 07/09/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675929
Principal investigator 1 Eli Lilly and Company $4,300.00 07/02/2021 Non-covered Recipient Entity
COMPASS RESEARCH EAST LLC
A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL COMPARING EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS SEMAGLUTIDE ONCE WEEKLY AS ADD-ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES No dispute reported 06/30/2026 819454853
Principal investigator 1 Novo Nordisk AS $2,469.95 06/28/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810695471
Principal investigator 1 PFIZER INC. $3,073.63 06/05/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832674347
Principal investigator 1 Eli Lilly and Company $47.50 05/31/2021 Non-covered Recipient Entity
SOUTHERN CALIFORNIA DERMATOLOGY INC
EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) No dispute reported 06/30/2026 819468917
Principal investigator 1 Novo Nordisk AS $4,025.27 05/28/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811272759
Principal investigator 1 PFIZER INC. $1,044.05 05/22/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675313
Principal investigator 1 PFIZER INC. $1,360.59 05/13/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832674941
Principal investigator 1 Eli Lilly and Company $47.50 04/30/2021 Non-covered Recipient Entity
DERMATOLOGY SPECIALISTS RESEARCH
EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) No dispute reported 06/30/2026 819456383
Principal investigator 1 Novo Nordisk AS $5,885.47 04/26/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771127
Principal investigator 1 PFIZER INC. $1,812.79 04/22/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675305
Principal investigator 1 PFIZER INC. $2,052.19 04/09/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675727
Principal investigator 1 Boehringer Ingelheim Pharmaceuticals, Inc. $800.00 03/30/2021 Non-covered Recipient Entity
Oviedo Medical Research
COPD pragmatic randomised clinical trial No dispute reported 06/30/2026 840493851
Principal investigator 1 Novo Nordisk AS $250.00 03/24/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771119
Principal investigator 1 Novo Nordisk AS $4,673.83 03/24/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270985
Principal investigator 1 PFIZER INC. $3,480.61 03/24/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675737
Principal investigator 1 PFIZER INC. $2,785.12 03/22/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832813861
Principal investigator 1 Novo Nordisk AS $139.34 03/17/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771007
Principal investigator 1 Novo Nordisk AS $139.34 03/17/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771767
Principal investigator 1 PFIZER INC. $6,962.80 03/03/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832806057
Recipient Eli Lilly and Company $396.44 03/01/2021 Covered Recipient Physician EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) No dispute reported 06/30/2026 819443489
Principal investigator 1 PFIZER INC. $1,444.38 02/24/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832675323
Principal investigator 1 Novo Nordisk AS $3,335.08 02/22/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771109
Principal investigator 1 PFIZER INC. $6,805.00 02/05/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832674339
Principal investigator 1 Eli Lilly and Company $106.10 01/29/2021 Non-covered Recipient Entity
COMPASS RESEARCH EAST LLC
A PHASE 3, RANDOMIZED, OPEN-LABEL TRIAL COMPARING EFFICACY AND SAFETY OF TIRZEPATIDE VERSUS SEMAGLUTIDE ONCE WEEKLY AS ADD-ON THERAPY TO METFORMIN IN PATIENTS WITH TYPE 2 DIABETES No dispute reported 06/30/2026 819455307
Principal investigator 1 Novo Nordisk AS $200.00 01/28/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 810771101
Principal investigator 1 Novo Nordisk AS $6,366.41 01/28/2021 Non-covered Recipient Entity
OVIEDO MEDICAL RESEARCH, LLC
EX9536-4388 No dispute reported 06/30/2026 811270853
Principal investigator 1 Eli Lilly and Company $7,201.31 01/11/2021 Non-covered Recipient Entity
COMPASS RESEARCH EAST LLC
EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) No dispute reported 06/30/2026 819454381
Principal investigator 1 Eli Lilly and Company $254,233.00 01/05/2021 Non-covered Recipient Entity
COMPASS RESEARCH EAST LLC
EFFICACY AND SAFETY OF TIRZEPATIDE ONCE WEEKLY IN PARTICIPANTS WITHOUT TYPE 2 DIABETES WHO HAVE OBESITY OR ARE OVERWEIGHT WITH WEIGHT- RELATED COMORBIDITIES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (SURMOUNT-1) No dispute reported 06/30/2026 819455415
Principal investigator 1 PFIZER INC. $2,785.12 01/04/2021 Non-covered Recipient Entity
Oviedo Medical Research LLC
A PHASE 3 RANDOMIZED ACTIVECONTROLLED OBSERVERBLINDED TRIAL TO ASSESS THE SAFETY TOLERABILITY AND IMMUNOGENICITY OF MENABCWY IN HEALTHY PARTICIPANTS 10 TO 26 YEARS OF AGE No dispute reported 06/30/2026 832918887